ExodusPoint Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.47M Buy
2023
Q4
Sell
2023
Q3
$1.67M Buy
2023
Q2
$1.54M Buy
2023
Q1
Sell
2022
Q4
$1.21M Buy
2022
Q3
$486K Buy
2021
Q2
Sell
2021
Q1
$351K Sell
2020
Q4
$613K Buy
2020
Q3
$316K Sell
2020
Q2
$1.09M Buy